Parameters | Units | In hospital | After discharge | |
---|---|---|---|---|
Under dosing tamoxifen | 7 days after tamoxifen withdrawal | 2 months after dosing pemafibrate | ||
Parameters related with lipid metabolism | ||||
TC | mg/dL | 341 | 282 | 234 |
TG | mg/dL | 964 | 675 | 231 |
HDL-C | mg/dL | 34 | 33 | 46 |
LDL-C | mg/dL | 68 | 114 | 156 |
non-HDL-C | mg/dL | 307 | 249 | 188 |
RLP-C | mg/dL | 59.0 | – | 11.3 |
Apo A-I | mg/dL | 148 | 153 | |
Apo B | mg/dL | 158 | 155 | 142 |
Apo C-II | mg/dL | 21.8 | 14.5 | 9.5 |
Apo C-III | mg/dL | 63.4 | 33.9 | 20.0 |
Apo C-III/C-II ratio | 2.9 | 2.3 | 2.1 | |
Apo E | mg/dL | 14.7 | 5.5 | |
LDL-C/ Apo B ratio | 0.51 | 0.73 | 1.10 | |
Lipoprotein fraction test (PAGE method) | ||||
HDL | % | 18 | 10 | 17 |
BAND 1 | % | 4 | 16 | |
LDL | % | 16 | 12 | 44 |
MIDBAND | % | 39 | 35 | 24 |
VLDL | % | 23 | 27 | 15 |
LDL-MI | 0.67 | 0.60 | 0.37 | |
Other parameters | ||||
HbA1c | % | 7.3 | – | 7.0 |
Cre | mg/dL | 1.40 | 1.00 | |
eGFR | ml/min/1.75m2 | 32.9 | 47.5 | |
P-Amy | U/L | 72 | 53 | – |